Norges Bank’s Kymera Therapeutics KYMR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.81M | Buy |
+41,370
| New | +$1.81M | ﹤0.01% | 1450 |
|
|
2025
Q1 | – | Sell |
-91,231
| Closed | -$3.67M | – | 898 |
|
|
2024
Q4 | $3.67M | Buy |
+91,231
| New | +$3.67M | ﹤0.01% | 1571 |
|
|
2024
Q3 | – | Sell |
-117,883
| Closed | -$3.52M | – | 928 |
|
|
2024
Q2 | $3.52M | Hold |
117,883
| – | – | ﹤0.01% | 1626 |
|
|
2024
Q1 | $4.74M | Sell |
117,883
-386,200
| -77% | -$15.5M | ﹤0.01% | 1629 |
|
|
2023
Q4 | $12.8M | Buy |
504,083
+386,200
| +328% | +$9.83M | ﹤0.01% | 1407 |
|
|
2023
Q3 | $1.64M | Sell |
117,883
-49,653
| -30% | -$690K | ﹤0.01% | 1850 |
|
|
2023
Q2 | $3.85M | Hold |
167,536
| – | – | ﹤0.01% | 1776 |
|
|
2023
Q1 | $4.96M | Sell |
167,536
-54,481
| -25% | -$1.61M | ﹤0.01% | 1759 |
|
|
2022
Q4 | $5.54M | Hold |
222,017
| – | – | ﹤0.01% | 1753 |
|
|
2022
Q3 | $4.83M | Sell |
222,017
-16,400
| -7% | -$357K | ﹤0.01% | 1772 |
|
|
2022
Q2 | $4.69M | Buy |
238,417
+99,726
| +72% | +$1.96M | ﹤0.01% | 1783 |
|
|
2022
Q1 | $5.87M | Buy |
138,691
+84,528
| +156% | +$3.58M | ﹤0.01% | 1840 |
|
|
2021
Q4 | $3.44M | Hold |
54,163
| – | – | ﹤0.01% | 1978 |
|
|
2021
Q3 | $3.18M | Buy |
54,163
+15,781
| +41% | +$927K | ﹤0.01% | 1989 |
|
|
2021
Q2 | $1.86M | Buy |
38,382
+16,352
| +74% | +$793K | ﹤0.01% | 2029 |
|
|
2021
Q1 | $856K | Buy |
22,030
+7,030
| +47% | +$273K | ﹤0.01% | 2063 |
|
|
2020
Q4 | $930K | Hold |
15,000
| – | – | ﹤0.01% | 2036 |
|
|
2020
Q3 | $485K | Buy |
+15,000
| New | +$485K | ﹤0.01% | 2082 |
|